SEPN (SEPN) Stock Price & Analysis
SEPN (SEPN) fell 0.14% to USD 36.75 as of September 8, 2026 at 06:22 UTC, according to Nexqual real-time market data.
SEPN last closed at USD 36.75; the session ranged USD 36.57–37.59 on volume of 199,666 shares. Market capitalization is —, with a 52-week range of USD 13.67–51.1 (NGM). Source: Nexqual, September 8, 2026 at 06:22 UTC.
Key Statistics (as of September 8, 2026 at 06:22 UTC)
| Price | USD 36.75 |
|---|---|
| Change | ▼ 0.14% (down) |
| Previous Close | USD 36.75 |
| Open | USD 36.75 |
| Day Range | USD 36.57 – 37.59 |
| 52-Week Range | USD 13.67 – 51.1 |
| Volume | 199,666 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (SEPN)
Nexqual's technical model rates SEPN "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:22 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.04 (neutral) |
| vs SMA50 | Below (USD 37.51) |
| MACD | -0.21 (negative) |
From SEPN's Latest SEC 10-K Filing (filed 2026-03-09)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBX | MBX Biosciences, Inc. | USD 61.72 | ▲ 1.36% |
| RAPP | Rapport Therapeutics, Inc. | USD 45.77 | ▼ 6% |
| BCAX | Bicara Therapeutics Inc. | USD 23.17 | ▼ 1.66% |
| UPB | Upstream Bio, Inc. | USD 6.01 | ▼ 7.25% |
| ALMS | Alumis Inc. | USD 11.1 | ▲ 7.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:22 UTC. This page is informational and not investment advice.